e-patient Dave DeBronkart published a review/profile of our project on the website of the JOPM. Excerpts:
“Why would someone interested in participatory medicine want to know about this? Learning to decode news articles about health and health care is essential to being a responsible driver of one’s health. It is impossible to act responsibly without good information. Too often the health stories we read have been poorly analyzed and reported on by today’s time-pressured reporters, as Schwitzer’s reviews make clear. The reviews and methodology presented on this site can help patients bring better quality information to the care relationship with their clinicians, and help all parties make better informed decisions.
Careful scrutiny of health news can be a potent enabler of participatory medicine because of the radical differences in focus between the patient, who must care for only their own illnesses and conditions, and the clinician, who must know about and manage many.
…
We consumers can help physicians stay informed about our health concerns by scouting or digging for relevant articles. Chances are we are not going to search first in the scientific literature, but rather in the news media. For us, this is where quality matters. We depend on accurate representation of new scientific findings by journalists: Is the finding new? How robust is it? At what point in the development process is the drug or treatment approach? Schwitzer’s team encourages better health news reporting by publicly critiquing the work of specific journalists while at the same time demonstrating to the public the criteria that each of us should apply in our own reading of the news. Because their criteria are presented in lay terms, they enable consumer participation in health decision making.”
Thanks to Dave and to the Journal for their interest in and support of our project and its goals.
Opinions on other issues in news, journals, PR, advertising, marketing
Monday at #ADA2021, an infectious disease epidemiologist, a journalist, and a researcher shared perspectives on communication of risk in the era of COVID-19: http://ow.ly/ROfR30rMeE7 @AstleyCM @garyschwitzer @berthahidalgo @ADA_DiabetesPro
Shoutouts to @susan_bewley @drkevinknopf @MichaelBaum11 in this call for more than fawning coverage from press releases for these kinds of stories.
Also, linked history inside goes back 5 years just on Grail apparently trying to become Holy Grail. https://twitter.com/garyschwitzer/status/1408849696416841731
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Comments are closed.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like